To request further information or to express interest in RAPClot Rapid serum tubes or in the use of high Quality recombinant ecarin for any diagnostic or medical device purpose, please complete the e-mail form below.
Or contact directly:
Michael Grant,
Chief Executive Officer
Q-Sera Pty Ltd
Level 9, 31 Queen St, Melbourne, 3000, Victoria, Australia.
To express interest in the 2025 Clinical Studies, please leave your details in the e-mail form below, stating Clinical Trials in the ‘Company’ space.